| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Bersiporocin
CAS:2241808-52-4
Remarks:Reach out to us for more information about custom solutions.
|
| Company Name: |
Nantong QuanYi Biotechnology Co., Ltd
|
| Tel: |
0513-66337626 18051384581 |
| Email: |
sales@chemhifuture.com |
| Products Intro: |
Product Name:Bersiporocin
CAS:2241808-52-4
Purity:98%+ HPLC Package:10mg，500mg，1g，2g，5g，10mg，more
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Bersiporocin
CAS:2241808-52-4
Purity:0 Package:5mg/RMB 8830
|
| Company Name: |
Shanghai Fine Biotech Co.，Ltd
|
| Tel: |
18221172427 |
| Email: |
sale@fine-biotech.com |
| Products Intro: |
Product Name:Bersiporocin
CAS:2241808-52-4
Purity:98%HPLC Package:100mg;250mg;1g;5g,10g;25g;100g
|
3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, (2R,3S)- manufacturers
- Bersiporocin
-
- $1430.00 / 5mg
-
2025-10-27
- CAS:2241808-52-4
- Min. Order:
- Purity: 99.39%
- Supply Ability: 10g
|
| | 3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, (2R,3S)- Basic information |
| | 3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, (2R,3S)- Chemical Properties |
| Boiling point | 516.8±60.0 °C(Predicted) | | density | 1.46±0.1 g/cm3(Predicted) | | pka | 14.88±0.40(Predicted) | | form | Solid | | color | White to off-white |
| | 3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, (2R,3S)- Usage And Synthesis |
| Uses | Bersiporocin is a prolyl-tRNA synthetase inhibitor. Bersiporocin has an IC50 of ≤100 nM for phosphoribosylpyrophosphate synthetase (PRS). Bersiporocin can be used for the research of antifibrotic[1][2]. | | IC 50 | PRS: ≤100 nM (IC50) | | References | [1] Bong-Yong Lee, et al. Heterocyclic compounds, preparation methods, pharmaceutical compositions, and use as pyrolyl-tRNA synthetase inhibitors.WO2018147626 A1
[2] WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022. |
| | 3-Piperidinol, 2-[3-(4,5-dichloro-1H-benzimidazol-1-yl)propyl]-, (2R,3S)- Preparation Products And Raw materials |
|